Skip to main content
. 2022 Apr 5;14(7):1831. doi: 10.3390/cancers14071831

Figure 2.

Figure 2

Approaches to neoadjuvant therapy for retroperitoneal sarcomas based on both general and histology-specific results from recent and ongoing studies; consistent with published guidelines from ESMO-EURACAN, TARPSWG, and the NCCN.